Posted in | News | Optics and Photonics

Clearview Signs Supply Agreement with Optical Components Provider Ignis

Clearfield, Inc. (NASDAQ: CLFD), a specialist in fiber management solutions for fiber to the premises (FTTp) deployments, and Ignis ASA, a leading international provider of optical components, announced today that they have signed a mutual supply agreement.

Under the terms of the agreement, the Korean manufacturing center of Ignis will be the preferred supplier of optical components to Clearfield. Ignis will sell this integrated solution exclusively through Clearfield.

“We are proud to team our wafer fabrication and array technology with the superior optical component packaging of the most innovative fiber management supplier in North America,” said Matt Lee, Chief Operating Officer of Ignis ASA. “As the leading provider of optical component products to the largest FTTH deployments in the world, Ignis is pleased to bring our standards of quality and delivery to Clearfield.”

“Clearfield has designed an optical component package that has been field-proven in the harshest of environments. Thousands have been deployed and have weathered the extremes of Alaska winters to Alabama summers,” explains Johnny Hill, Chief Operating Officer of Clearfield. “Our partnership with Ignis cements our ability to provide an increasing volume of highly reliable, quality products.”

“With monies beginning to flow from the Broadband Stimulus program, we are seeing a number of FTTH projects receive funding,” explains Cheri Beranek, president and CEO of Clearfield. “This agreement is one means by which Clearfield is assuring our customers and prospects that Clearfield can respond to their quality, delivery and cost requirements.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.